Late Breaking Abstract - Real-world effectiveness of 20-valent pneumococcal conjugate vaccine among older adults in the United States - Amsterdam 2025

Clinical impact and immunisation strategies in viral respiratory infections

Chair(s): Saqib Baig, Mateja Jankovic Makek

Session type: Poster session

Late Breaking Abstract - Real-world effectiveness of 20-valent pneumococcal conjugate vaccine among older adults in the United States

Jelena Vojicic

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Influenza, Pneumococcal, COVID-19 Vaccine Coverage and Hesitancy in Chinese Older Adults from September 2022 to November 2022: A Nationwide Cross-sectional Study

Dong Liu

Poster

Abstract

Study on factors associated with prolonged viral shedding among inpatients with influenza A treated with oseltamivir

Yajuan Chen

Abstract

Predictors for detection of respiratory viruses in adults hospitalised with acute respiratory infection (ARI)

Tommaso Morelli

Poster

Abstract

RSV infection outcomes in high-risk patients: A two year retrospective study

Georgios-ioannis Poupouzas

Poster

Abstract

Understanding parental hesitancy about childhood flu vaccination: a qualitative study applying the Necessity Concerns Framework

Robert Horne

Poster

Abstract

Respiratory Syncytial Virus (RSV) related adult-at-risk population for hospitalisation in the era of new vaccines

Tanvi Sinha

Poster

Abstract

Clinical course and disease burden of RSV-infected hospitalized adults in Germany

Christopher Alexander Hinze

Poster

Abstract

Epidemiology, clinical course and complications of RSV infection in older adults in the outpatient sector in Germany

Christopher Alexander Hinze

Poster

Abstract

A systematic literature review of rhinovirus infection in adults with asthma

Isabelle Boucot

Poster

Abstract

Mortality for COPD patients after influenza A and RSV infection: a territory-wide retrospective analysis

Ka Pang Chan

Poster

Abstract

Vaccination recommendations in adults with chronic respiratory diseases

Susanne M. Huijts

Poster

Abstract

An evaluation of COPD and asthma-indicated medical visits after Respiratory Syncytial Virus infection

Rikisha Shah Gupta

Abstract

All-cause mortality associated with respiratory syncytial virus (RSV) infection compared to influenza infection in adults: Is infection with RSV riskier than influenza?

Rikisha Shah Gupta

Abstract

Burden of Respiratory Syncytial Virus (RSV) across age groups in Switzerland: Data from the Federal Statistical Office

Maria Boesing

Poster

Abstract

Characteristics of patients hospitalized with respiratory syncytial virus (RSV) in a Swiss public teaching hospital

Maria Boesing

Poster

Abstract

Effects of baloxavir marboxil plus neuraminidase inhibitor versus neuraminidase inhibitor in high-risk patients hospitalized with severe influenza: a post hoc analysis of the Flagstone trial

Yeming Wang

Poster

Abstract

Viral etiologies of respiratory infections in the post-COVID-19 pandemic era

Ali Zerouki

Poster

Abstract

Hospitalizations for viral lower respiratory tract disease (LRTD) in France: national study on an epidemic season based on PMSI data (BIRD-IC study)

Delphine Leynaud

Poster

Abstract

Late Breaking Abstract - Real-world effectiveness of 20-valent pneumococcal conjugate vaccine among older adults in the United States

Jelena Vojicic

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}